Pillstats
Rx only · Tablet · Oral

Guanfacine

Guanfacine Hydrochloride

16 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US26 NDCs
16 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers16 labelers
Packages41
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 19 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.063$0.126$0.189$0.253Dec 2025Mar 2026Jun 2026
$0.200
Latest avg · Jun 17, 2026
-9%
Since Dec 17, 2025
16
Active US suppliers
34%
Top-2 supplier share*

Who makes it16 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Advagen Pharma Ltdunknown8SUPPLYING
Actavis Pharma, Inc.unknown6SUPPLYING
Amneal Pharmaceuticals LLCunknown5SUPPLYING
Proficient Rx LPunknown3SUPPLYING
TWi Pharmaceuticals, Inc.unknown2SUPPLYING
Ajanta Pharma USA Inc.unknown2SUPPLYING
Amneal Pharmaceuticals of New York LLCunknown2SUPPLYING
Epic Pharma, LLCunknown2SUPPLYING
Chartwell RX, LLCunknown2SUPPLYING
Coupler LLCunknown2SUPPLYING
REMEDYREPACK INC.repackager2SUPPLYING
Precision Dose, Inc.unknown1SUPPLYING
Major Pharmaceuticalsunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
AvPAKunknown1SUPPLYING

+ 1 more labelers

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.